-
MorphoSys AG v. Janssen Biotech Inc. et al DC
- 1:16-cv-00221
- D. Del.
- Judge: Leonard P. Stark +1
- Filed: 04/04/2016
- Closed: 01/31/2019
- Latest Docket Entry: 02/01/2019
- PACER
- Docket updated daily
1
Plaintiff
3
Defendants
1
Accused
Product
3
Patents-in-Suit
1,033
Days in
Litigation
-
MorphoSys AG v. Janssen Biotech Inc. et al DC
- 1:16-cv-00221
- D. Del.
- Judge: Leonard P. Stark +1
- Filed: 04/04/2016
- Closed: 01/31/2019
- Latest Docket Entry: 02/01/2019
- PACER
- Docket updated daily
Causes of Action
Infringement
Willful Patent Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Genmab A/S
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Darzalex (daratumumab) | US 8,263,746 B2 |
18
|
Infringement
Entry 466
|
Darzalex (daratumumab) | US 9,200,061 B2 |
1, 5, 6, 11, 12
|
Infringement
Entry 466
|
Genmab US, Inc.
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Darzalex (daratumumab) | US 8,263,746 B2 |
18
|
Infringement
Entry 466
|
Darzalex (daratumumab) | US 9,200,061 B2 |
1, 5, 6, 11, 12
|
Infringement
Entry 466
|
Janssen Biotech, Inc.
- 2 Details
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
Darzalex (daratumumab) | US 8,263,746 B2 |
18
|
Infringement
Entry 466
|
Darzalex (daratumumab) | US 9,200,061 B2 |
1, 5, 6, 11, 12
|
Infringement
Entry 466
|